PVR and cancer: In addition, the presence of CD155 on the surface of cancer cells has been shown to promote tumor invasiveness, and its upregulation in tumor-infiltrating myeloid cells restrains antitumor immunity by impairing the function of antitumor T lymphocytes and NK cells (Bronte, 2018).